RNA 표적 소분자 신약 개발 시장 보고서(2026년)

RNA-targeting small-molecule drug discovery involves the identification and development of small-molecule compounds that bind to RNA molecules to influence their function or activity. This approach supports the development of novel therapies for the treatment of multiple conditions, including genetic disorders, viral infections, neurodegenerative diseases, and cancer.

The main type of RNA-targeting small-molecule drug discovery include messenger RNA (mRNA), non-coding RNA (ncRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). Messenger RNA (mRNA) is an RNA molecule responsible for transferring genetic information from DNA in the cell nucleus to ribosomes, where proteins are synthesized. The technologies used include CRISPR-Cas9, RNA aptamers, small interfering RNA (siRNA), ribozymes, and other approaches applied across several therapeutic areas such as oncology, neurology, infectious diseases, metabolic disorders, genetic conditions, and others. Delivery methods include intravenous (IV), oral, topical, and other routes, and these solutions are utilized for research, therapeutic, diagnostic, and other applications.

Tariffs have influenced the rna targeting small molecule drug discovery market by increasing costs of imported laboratory instruments, specialized reagents, and high-throughput screening technologies used in early-stage research. these impacts are most pronounced across research use and therapeutic development segments, particularly in regions dependent on cross-border biotech supply chains such as asia-pacific and europe. oncology and genetic disorder pipelines face longer development timelines due to higher input costs. however, tariffs are also encouraging localized manufacturing, regional r&d expansion, and strategic sourcing, which may strengthen domestic innovation ecosystems over the long term.

The rna targeting small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides rna targeting small molecule drug discovery market statistics, including rna targeting small molecule drug discovery industry global market size, regional shares, competitors with a rna targeting small molecule drug discovery market share, detailed rna targeting small molecule drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the rna targeting small molecule drug discovery industry. This rna targeting small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rna targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $2.13 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to limited druggability of protein targets, rising prevalence of genetic disorders, advances in rna biology research, growth in academic-industry collaborations, early success of rna-based therapeutics.

The rna targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $6.04 billion in 2030 at a compound annual growth rate (CAGR) of 23.5%. The growth in the forecast period can be attributed to ai-enabled rna target identification, increasing investment in precision medicine, expansion of rna therapeutics pipelines, improved rna delivery technologies, regulatory support for novel modalities. Major trends in the forecast period include ai-driven rna structure prediction, expansion of rna-targeted oncology pipelines, advances in rna-specific small molecule libraries, improved rna binding selectivity and specificity, integration of multi-omics in rna drug discovery.

The rising incidence of cancer, genetic disorders, and viral infections is expected to support the expansion of the RNA-targeted small-molecule drug discovery market in the coming years. Cancer encompasses a range of diseases marked by uncontrolled cell growth within the body. Viral infections are caused by viruses, which are microscopic infectious agents that replicate only inside living cells. RNA-targeted drug discovery is applied in the treatment of cancer, genetic disorders, and viral infections because these conditions are associated with genetic abnormalities or dysfunctional genetic material, which can be addressed using drugs developed through RNA-targeting approaches. For example, in February 2024, according to a report released by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded worldwide in 2022. Lung cancer accounted for the highest number of cases at 2.5 million (12.4%), followed by female breast cancer with 2.3 million cases (11.6%), colorectal cancer with 1.9 million cases (9.6%), prostate cancer with 1.5 million cases (7.3%), and stomach cancer with 970,000 cases (4.9%). By 2050, the number of new cancer cases is projected to increase by 77%, exceeding 35 million annually. As a result, the growing prevalence of cancer, genetic disorders, and viral infections is driving the growth of the RNA-targeted small-molecule drug discovery market.

Key companies operating in the RNA-targeting small-molecule drug discovery market are introducing advanced solutions such as software-as-a-service platforms to strengthen their competitive position. Software-as-a-service (SaaS) is a delivery model in which software applications are hosted by external providers and accessed by users through the Internet. For instance, in December 2023, Merck & Co. Inc., a US-based science and technology company, launched AIDDISON. This platform recommends optimal methods for synthesizing selected drug candidates. Such an approach has the potential to significantly reduce costs associated with drug discovery and improve the likelihood of successfully bringing new therapies to patients. By connecting virtual molecular design with practical manufacturability, the platform enhances treatment delivery by uncovering valuable insights from large datasets. To accelerate drug development timelines, this AI-driven system combines computer-aided drug design, machine learning, and generative artificial intelligence.

In June 2025, Novartis AG, a Switzerland-based company specializing in pharmaceuticals, gene therapies, and innovative medicines, acquired Regulus Therapeutics Inc. for up to $1.7 billion. This acquisition is intended to reinforce Novartis's renal disease pipeline by gaining access to Regulus's lead microRNA inhibitor for autosomal dominant polycystic kidney disease (ADPKD) and advancing its capabilities in RNA-targeted drug discovery. Regulus Therapeutics Inc. is a US-based clinical-stage biopharmaceutical company focused on discovering and developing therapies that target microRNAs.

Major companies operating in the rna targeting small molecule drug discovery market are F. Hoffmann-La Roche Ltd, Novartis AG, Bristol-Myers Squibb Company, Moderna Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics, Arbutus Biopharma Corporation, Arbutus Biopharma Corporation

North America was the largest region in the RNA-targeting small molecule drug discovery market in 2025. The regions covered in the rna targeting small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rna targeting small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The RNA targeting small molecule drug discovery market consists of revenues earned by entities by providing hit identification, hit validation, and hit characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA-targeting small molecule drug discovery market also includes sales of asRNAs and siRNAs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

RNA Targeting Small Molecule Drug Discovery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rna targeting small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rna targeting small molecule drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rna targeting small molecule drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Target RNA Type: Messenger RNA (mRNA); Non-Coding RNA (ncRNA); MicroRNA (miRNA); Long Non-Coding RNA (lncRNA)
• 2) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Metabolic Diseases; Genetic Disorders; Other Therapeutic Areas
• 3) By Delivery Method: Intravenous (IV); Oral; Topical; Other Methods
• 4) By Application: Research Use; Therapeutic Use; Diagnostic Use; Other Applications
• Subsegments:
• 1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding; Modulation Of mRNA Stability; mRNA Translation Inhibition
• 2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA; Small Nuclear RNA; Small Nucleolar RNA
• 3) By MicroRNA (miRNA): miRNA Inhibition; miRNA Mimics; Targeting Specific miRNA Pathways
• 4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators; Targeting Specific lncRNA Functions; Therapeutic Applications Of lncRNA
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Novartis AG; Bristol-Myers Squibb Company; Moderna Inc.; Biogen Inc.; Alnylam Pharmaceuticals Inc.; Sarepta Therapeutics Inc.; Evotec A.G.; PTC Therapeutics Inc.; Ionis Pharmaceuticals Inc.; Dicerna Pharmaceuticals Inc.; Arrakis Therapeutics; H3 Biomedicine Inc.; Anima Biotech Inc.; Ribometrix Inc.; Quark Pharmaceuticals Inc.; Regulus Therapeutics Inc.; Skyhawk Therapeutics Inc.; Accent Therapeutics Inc.; Epics Therapeutics; Expansion Therapeutics; Arbutus Biopharma Corporation; Arbutus Biopharma Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. RNA Targeting Small Molecule Drug Discovery Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global RNA Targeting Small Molecule Drug Discovery Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. RNA Targeting Small Molecule Drug Discovery Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global RNA Targeting Small Molecule Drug Discovery Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 AI-Driven RNA Structure Prediction
  • 4.2.2 Expansion Of RNA-Targeted Oncology Pipelines
  • 4.2.3 Advances In RNA-Specific Small Molecule Libraries
  • 4.2.4 Improved RNA Binding Selectivity And Specificity
  • 4.2.5 Integration Of Multi-Omics In RNA Drug Discovery

5. RNA Targeting Small Molecule Drug Discovery Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Academic And Research Institutes
• 5.4 Contract Research Organizations (CROs)
• 5.5 Diagnostic Laboratories

6. RNA Targeting Small Molecule Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global RNA Targeting Small Molecule Drug Discovery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global RNA Targeting Small Molecule Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global RNA Targeting Small Molecule Drug Discovery Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global RNA Targeting Small Molecule Drug Discovery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global RNA Targeting Small Molecule Drug Discovery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global RNA Targeting Small Molecule Drug Discovery Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. RNA Targeting Small Molecule Drug Discovery Market Segmentation

• 9.1. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
• 9.2. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
• 9.3. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intravenous (IV), Oral, Topical, Other Methods
• 9.4. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research Use, Therapeutic Use, Diagnostic Use, Other Applications
• 9.5. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Messenger RNA (mRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Targeting mRNA For Protein Coding, Modulation Of mRNA Stability, mRNA Translation Inhibition
• 9.6. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Non-Coding RNA (ncRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Long Non-Coding RNA, Small Nuclear RNA, Small Nucleolar RNA
• 9.7. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of MicroRNA (miRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• miRNA Inhibition, miRNA Mimics, Targeting Specific miRNA Pathways
• 9.8. Global RNA Targeting Small Molecule Drug Discovery Market, Sub-Segmentation Of Long Non-Coding RNA (lncRNA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• lncRNA Modulators, Targeting Specific lncRNA Functions, Therapeutic Applications Of lncRNA

10. RNA Targeting Small Molecule Drug Discovery Market Regional And Country Analysis

• 10.1. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market

• 11.1. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China RNA Targeting Small Molecule Drug Discovery Market

• 12.1. China RNA Targeting Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India RNA Targeting Small Molecule Drug Discovery Market

• 13.1. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan RNA Targeting Small Molecule Drug Discovery Market

• 14.1. Japan RNA Targeting Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia RNA Targeting Small Molecule Drug Discovery Market

• 15.1. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia RNA Targeting Small Molecule Drug Discovery Market

• 16.1. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea RNA Targeting Small Molecule Drug Discovery Market

• 17.1. South Korea RNA Targeting Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan RNA Targeting Small Molecule Drug Discovery Market

• 18.1. Taiwan RNA Targeting Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia RNA Targeting Small Molecule Drug Discovery Market

• 19.1. South East Asia RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe RNA Targeting Small Molecule Drug Discovery Market

• 20.1. Western Europe RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK RNA Targeting Small Molecule Drug Discovery Market

• 21.1. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany RNA Targeting Small Molecule Drug Discovery Market

• 22.1. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France RNA Targeting Small Molecule Drug Discovery Market

• 23.1. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy RNA Targeting Small Molecule Drug Discovery Market

• 24.1. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain RNA Targeting Small Molecule Drug Discovery Market

• 25.1. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market

• 26.1. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia RNA Targeting Small Molecule Drug Discovery Market

• 27.1. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America RNA Targeting Small Molecule Drug Discovery Market

• 28.1. North America RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA RNA Targeting Small Molecule Drug Discovery Market

• 29.1. USA RNA Targeting Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada RNA Targeting Small Molecule Drug Discovery Market

• 30.1. Canada RNA Targeting Small Molecule Drug Discovery Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America RNA Targeting Small Molecule Drug Discovery Market

• 31.1. South America RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil RNA Targeting Small Molecule Drug Discovery Market

• 32.1. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East RNA Targeting Small Molecule Drug Discovery Market

• 33.1. Middle East RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa RNA Targeting Small Molecule Drug Discovery Market

• 34.1. Africa RNA Targeting Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Segmentation By Therapeutic Area, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. RNA Targeting Small Molecule Drug Discovery Market Regulatory and Investment Landscape

36. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

• 36.1. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. RNA Targeting Small Molecule Drug Discovery Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. RNA Targeting Small Molecule Drug Discovery Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. RNA Targeting Small Molecule Drug Discovery Market Other Major And Innovative Companies

• Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics

38. Global RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The RNA Targeting Small Molecule Drug Discovery Market

40. RNA Targeting Small Molecule Drug Discovery Market High Potential Countries, Segments and Strategies

• 40.1 RNA Targeting Small Molecule Drug Discovery Market In 2030 - Countries Offering Most New Opportunities
• 40.2 RNA Targeting Small Molecule Drug Discovery Market In 2030 - Segments Offering Most New Opportunities
• 40.3 RNA Targeting Small Molecule Drug Discovery Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer